Compare · 3 funds side by side · dividends reinvested

MDEV, XLV and VOO

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$18,115VOO · best of the three

02 / 04

MDEV, XLV and VOO, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard S&P 500 ETFLow-Cost Core · S&P 5000.03%1.05%+13.4%+13.5%+24.2%+12.6%−8.9%12.8%$1.00T1.5

State Street Health Care Select Sector SPDR ETFSectors · Health care0.08%1.34%+24.0%+33.5%+17.2%+9.4%−10.5%16.6%$49.1B1.6

First Trust Indxx Medical Devices ETFSectors · Health care0.70%0.09%+11.0%+14.2%+10.6%−1.5%−18.2%17.3%$3M2.9

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 4, 2026 · returns include dividends · since: MDEV 2021 · XLV 1998 · VOO 2010

Head to Head

Swap sides Versus in desk

Head to Head

First Trust Indxx Medical Devices ETF · $3M$9,263

MDEV

XLV

State Street Health Care Select Sector SPDR ETF · $49.1B$15,652

$10,000 five years ago, dividends reinvested · they hold 19.6% in common

MDEVMeasureXLV

+11.0%Year to dateJan 1 → Nov 4+24.0%

+14.2%1 yearTotal return+33.5%

+10.6%3 years · per year$10,000 became $13,541 · $16,102+17.2%

−1.5%5 years · per year$10,000 became $9,263 · $15,652+9.4%

0.70%Expense ratio$70 · $8 a year on $10k · lower is better0.08%

0.09%Trailing 12-mo yield$9 · $134 a year on $10k1.34%

−18.2%Worst dropSmaller is better−10.5%

17.3%VolatilityLower is calmer16.6%

MDEVXLV Winner of the row, in its colourEach row: the bigger of the two fills its side

0–8XLV wins

End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

MDEV vs XLV: Top 5 Holdings

Today

MDEV

11.2%in top 5

XLV

in top 544.9%

MDEVStockXLV

not top 5LLY16.9%

not top 5JNJ9.6%

not top 5ABBV7.6%

not top 5UNH5.4%

not top 5MRK5.3%

2.4%GEHCnot top 5

2.3%PHIA.ASnot top 5

2.2%PODDnot top 5

2.2%ALC.SWnot top 5

2.2%STMN.SWnot top 5

Held in common19.6%

End-of-day Nov 4, 2026 · share of each fund

MDEV vs XLV Returns, Every Period

First TrustMDEV

−1.5%

5 years, per year

XLVSPDR

+9.4%

5 years, per year

MDEVXLVFaded: behind in that period

0–4XLV wins

End-of-day Nov 4, 2026 · dividends in · faded = behind in that period

MDEV vs XLV

YTD

First TrustMDEV

+11.0%

XLVSPDR

+24.0%

+11.0%Year to date+24.0%

−18.2%Worst drop · 1Y−10.5%

17.3%Volatility · 1Y16.6%

0.1%Yield1.3%

$3.3MAssets$49.1B

4–0XLV wins

End-of-day Nov 4, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: MDEV, XLV, VOO

Today

0.03%lowest, VOO

FundExpense ratioFee$10k

VOO0.03%$3

XLV0.08%$8

MDEV0.70%$70

End-of-day Nov 4, 2026 · fee on $10,000 a year

Yields: MDEV, XLV, VOO

1.34%highest, XLV

FundTrailing yieldYield$10k

XLV1.34%$134

VOO1.05%$105

MDEV0.09%$9

End-of-day Nov 4, 2026 · trailing 12-month yield

Income After Fees on $10,000

$126most kept, XLV

XLV$134 − $8 = $126

VOO$105 − $3 = $102

MDEV$9 − $70 = −$61

KeptFee

End-of-day Nov 4, 2026 · yield in dollars minus the fee

Overlap: MDEV, XLV, VOO

Today

19.6%most shared, MDEV and XLV

MDEVXLVVOO

MDEV—19.6%2.1%

XLV19.6%—9.3%

VOO2.1%9.3%—

End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+33.5%XLV, at 16.6% volatility

VOOWorst drop−8.9%12.8% vol

XLVWorst drop−10.5%16.6% vol

MDEVWorst drop−18.2%17.3% vol

End-of-day Nov 4, 2026 · up and left is better

Paid More vs Made More

YTD

XLVVOO

+24.0%Year to date+13.4%

1.3%Yield1.1%

+33.5%Past year+13.5%

0.08%Fee0.03%

3–1XLV wins

End-of-day Nov 4, 2026

Popular Pairs Near These Three

SPYM vs SPY

YTD

SPDRSPYM

+13.4%

SPYSPDR

+13.3%

+13.4%Year to date+13.3%

1.0%Yield1.0%

$185BAssets$798B

1–0SPYM wins

End-of-day Nov 4, 2026

VOO vs IVV

YTD

VanguardVOO

+13.4%

IVViShares

+13.4%

+13.4%Year to date+13.4%

1.1%Yield1.1%

$1.00TAssets$872B

0–0level

End-of-day Nov 4, 2026

SCHD vs VIG

YTD

SchwabSCHD

+35.3%

VIGVanguard

+16.4%

+35.3%Year to date+16.4%

2.9%Yield1.4%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 4, 2026